CareMax (CMAX) Misses Q2 EPS by 21c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts CMAX Hot Sheet
Join SI Premium – FREE
CareMax (NASDAQ: CMAX) reported Q2 EPS of ($0.29), $0.21 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $224.4 million versus the consensus estimate of $184.41 million.
GUIDANCE:
CareMax sees FY2023 revenue of $750-800 million, versus the consensus of $740 million.
For earnings history and earnings-related data on CareMax (CMAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
- Preferred Bank (PFBC) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
